SUMER JACQUELYN L Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
8
Insider Sells Sum
$98,925.30

Insider Activity of SUMER JACQUELYN L

According to the SEC Form 4 filings, SUMER JACQUELYN L, being in a position of

  1. Chief Legal Officer at Cullinan Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 10823 shares for $136,724,
    over all time since 2023-03-20, has bought 0 shares, and sold 20928 shares for $235,649.

Biography of SUMER JACQUELYN L

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $136,7243100

Comparison of Insiders on Amount of Buys and Sells

2026-02-24SaleCullinan Therapeutics, Inc.
CGEM
Chief Legal Officer
3,601
0.0062%
$14.47$52,106+8.34%
2026-02-20SaleCullinan Therapeutics, Inc.
CGEM
Chief Legal Officer
3,742
0.0063%
$13.62$50,966+13.19%
2025-12-18SaleCullinan Therapeutics, Inc.
CGEM
Chief Legal Officer
3,480
0.0057%
$9.67$33,652+49.5%
2025-02-25SaleCullinan Oncology, Inc.
CGEM
Chief Legal Officer
3,756
0.0061%
$8.53$32,039-4.91%
2024-12-18SaleCullinan Oncology, Inc.
CGEM
Chief Legal Officer
3,482
0.0064%
$11.41$39,730-24.47%
2023-12-21SaleCullinan Oncology, Inc.
CGEM
Chief Legal Officer
1,400
0.0029%
$8.50$11,900+79.11%
2023-12-18SaleCullinan Oncology, Inc.
CGEM
Chief Legal Officer
290
0.0006%
$8.22$2,384+85.76%
2023-06-20SaleCullinan Oncology, Inc.
CGEM
Chief Legal Officer
291
0.0007%
$12.94$3,766-16.6%
2023-05-18SaleCullinan Oncology, Inc.
CGEM
Chief Legal Officer
291
0.0007%
$8.76$2,549+20.45%
2023-04-18SaleCullinan Oncology, Inc.
CGEM
Chief Legal Officer
290
0.0007%
$10.71$3,106+1.31%
2023-03-20SaleCullinan Oncology, Inc.
CGEM
Chief Legal Officer
305
0.0008%
$11.32$3,453-5.51%
Total: 11
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.